Clinical Trial
Published on 06 Apr 2023
Impact of glucagon-like peptide 1 receptor agonist liraglutide and dipeptidyl peptidase-4 inhibitor sitagliptin on bowel cleaning and gastrointestinal symptoms in type 2 diabetes
in Gastrointestinal and Hepatic Pharmacology
![Impact of glucagon-like peptide 1 receptor agonist liraglutide and dipeptidyl peptidase-4 inhibitor sitagliptin on bowel cleaning and gastrointestinal symptoms in type 2 diabetes](https://www.frontiersin.org/files/myhome article library/1176206/1176206_Thumb_400.jpg)
- 2,980 views
- 3 citations